Difference between revisions of "Carcinoma ex pleomorphic adenoma"
Jump to navigation
Jump to search
Line 24: | Line 24: | ||
| Rads = | | Rads = | ||
| Endoscopy = | | Endoscopy = | ||
| Prognosis = typically poor | | Prognosis = dependent on stage, typically poor | ||
| Other = | | Other = | ||
| ClinDDx = | | ClinDDx = | ||
Line 40: | Line 40: | ||
Epidemiology: | Epidemiology: | ||
*Rare. | *Rare. | ||
* | *Prognosis dependent on stage: | ||
**Good for early lesions - like PA.<ref name=pmid23821206/> | |||
**Poor for advanced lesions.<ref name=pmid21744105/> | |||
==Gross== | ==Gross== | ||
Line 80: | Line 82: | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311945/figure/Fig1/ Ca ex PA - showing ca and PA areas (nih.gov)].<ref name=pmid21744105/> | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311945/figure/Fig1/ Ca ex PA - showing ca and PA areas (nih.gov)].<ref name=pmid21744105/> | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311945/figure/Fig2/ Ca ex PA - showing capsule invasion (nih.gov)]. | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311945/figure/Fig2/ Ca ex PA - showing capsule invasion (nih.gov)]. | ||
==IHC== | |||
Features - ca ex PA vs PA:<ref name=pmid23821206>{{Cite journal | last1 = Di Palma | first1 = S. | title = Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. | journal = Head Neck Pathol | volume = 7 Suppl 1 | issue = | pages = S68-76 | month = Jul | year = 2013 | doi = 10.1007/s12105-013-0454-z | PMID = 23821206 }}</ref> | |||
*Ki-67 elevated. | |||
*HER2 +ve | |||
*p53 +ve. | |||
==See also== | ==See also== |
Revision as of 17:35, 23 November 2013
Carcinoma ex pleomorphic adenoma | |
---|---|
Diagnosis in short | |
LM DDx | salivary duct carcinoma, mucoepidermoid carcinoma, adenoid cystic carcinoma, pleomorphic adenoma |
Gross | firm |
Site | salivary gland - usu. parotid gland |
| |
Signs | usu. parotid mass, firm |
Prevalence | uncommon |
Prognosis | dependent on stage, typically poor |
Carcinoma ex pleomorphic adenoma, abbreviated ca ex PA, is a rare malignant salivary gland tumour that arise from a pleomorphic adenoma.
General
Definition:
- Malignancy arising from a pleomorphic adenoma.[1]
Diagnosis (either 1 or 2):
- History of a pleomorphic adenoma at the same site.
- Features of a pleomorphic adenoma and a carcinoma.
Epidemiology:
- Rare.
- Prognosis dependent on stage:
Gross
- Usually mass lesion - partoid gland.[1]
Microscopic
Features:
- Cells with cytologic features of malignancy - key feature.
- Architecture (any of the following):
- Glands.
- Nests.
- Single cells (may be subtle).
Architectural patterns:
- Ductal carcinoma NOS (arising from ductal cells) - most common pattern for Ca ex PA.
- Myoepithelial carcinoma NOS (arising from myoepithelial cells).
- "Named carcinoma":
- Salivary duct carcinoma - second most common pattern for Ca ex PA.
- Mucoepidermoid carcinoma.
- Adenoid cystic carcinoma.
Note:
- Often adenocarcinoma-like.
- Myoepithelial cells may be clear cells.
DDx:
Subclassification
Extent of invasion:[3]
- Non-invasive AKA intracapsular AKA in situ.
- Minimally invasive <=1.5 mm beyond the capsule.
- Widely invasive >1.5 mm beyond the capsule.
Images
IHC
Features - ca ex PA vs PA:[2]
- Ki-67 elevated.
- HER2 +ve
- p53 +ve.
See also
References
- ↑ 1.0 1.1 1.2 1.3 Antony, J.; Gopalan, V.; Smith, RA.; Lam, AK. (Mar 2012). "Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data.". Head Neck Pathol 6 (1): 1-9. doi:10.1007/s12105-011-0281-z. PMID 21744105.
- ↑ 2.0 2.1 Di Palma, S. (Jul 2013). "Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.". Head Neck Pathol 7 Suppl 1: S68-76. doi:10.1007/s12105-013-0454-z. PMID 23821206.
- ↑ URL: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/MajorSalGlands_11protocol.pdf. Accessed on: 2 April 2012.